Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00220_DB00425_nanopub.RAs6b0birTxQ-sq6KkJFW6HZtDcPxc4uPc2dQRh-hAnj0#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00220_DB00425 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00220_DB00425 label "DDI between Nelfinavir and Zolpidem - Nelfinavir, a strong CYP3A4 inhibitor, may increase the serum concentration of zolpidem by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zolpidem if nelfinavir is initiated, discontinued or dose changed. [drugbank_resource:DB00220_DB00425]" assertion.
- drugbank_resource:DB00220_DB00425 identifier "drugbank_resource:DB00220_DB00425" assertion.
- drugbank_resource:DB00220_DB00425 title "DDI between Nelfinavir and Zolpidem - Nelfinavir, a strong CYP3A4 inhibitor, may increase the serum concentration of zolpidem by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zolpidem if nelfinavir is initiated, discontinued or dose changed." assertion.
- drugbank:DB00220 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00220_DB00425 assertion.
- drugbank:DB00425 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00220_DB00425 assertion.